If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Claudia Chiodoni is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 4 Similar Profiles
Neoplasms Medicine & Life Sciences
trabectedin Medicine & Life Sciences
Dendritic Cells Medicine & Life Sciences
Interleukin-12 Medicine & Life Sciences
Myeloid Cells Medicine & Life Sciences
T-Lymphocytes Medicine & Life Sciences
Cysteine Medicine & Life Sciences
Extracellular Matrix Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1994 2019

  • 3129 Citations
  • 27 h-Index
  • 56 Article
  • 3 Review article
  • 1 Conference contribution
  • 1 Comment/debate

Cell communication and signaling: how to turn bad language into positive one

Chiodoni, C., Di Martino, M. T., Zazzeroni, F., Caraglia, M., Donadelli, M., Meschini, S., Leonetti, C. & Scotlandi, K., Mar 13 2019, In : Journal of Experimental and Clinical Cancer Research. 38, 1, p. 1-11 11 p.

Research output: Contribution to journalArticle

Cell Communication
Language
Neoplasms
Epithelial-Mesenchymal Transition
Tumor Microenvironment
Open Access
Confusion
Cell Communication
Names
Publications
Language
3 Citations (Scopus)

Immune checkpoint ligand reverse signaling: Looking back to go forward in cancer therapy

Lecis, D., Sangaletti, S., Colombo, M. P. & Chiodoni, C., May 2019, In : Cancers. 11, 5, 624.

Research output: Contribution to journalArticle

Open Access
Ligands
Neoplasms
Therapeutics
Renal Cell Carcinoma
Non-Small Cell Lung Carcinoma

Phenethyl isothiocyanate hampers growth and progression of HER2-positive breast and ovarian carcinoma by targeting their stem cell compartment

Koschorke, A., Faraci, S., Giani, D., Chiodoni, C., Iorio, E., Canese, R., Colombo, M. P., Lamolinara, A., Iezzi, M., Ladomery, M., Vernieri, C., de Braud, F., Di Nicola, M., Tagliabue, E., Castagnoli, L. & Pupa, S. M., Dec 1 2019, In : Cellular Oncology. 42, 6, p. 815-828 14 p.

Research output: Contribution to journalArticle

1 Citation (Scopus)

SPARC is a new myeloid-derived suppressor cell marker licensing suppressive activities

Sangaletti, S., Talarico, G., Chiodoni, C., Cappetti, B., Botti, L., Portararo, P., Gulino, A., Consonni, F. M., Sica, A., Randon, G., Nicola, M. D., Tripodo, C. & Colombo, M. P., Jan 1 2019, In : Frontiers in Immunology. 10, JUN, 1369.

Research output: Contribution to journalArticle

Open Access
Licensure
Cysteine
Proteins
Epithelial-Mesenchymal Transition
NF-kappa B